Literature DB >> 10529369

p53 down-regulates ER-responsive genes by interfering with the binding of ER to ERE.

G Liu1, J A Schwartz, S C Brooks.   

Abstract

Overexpression of the tumor suppressor p53 in HeLa cells leads to loss of the estradiol- and genistein-induced human estrogen receptor (ERalpha) transactivity. The coactivator p300, which binds to both ERalpha and p53, does not prevent this loss of hERalpha function. In this report we demonstrate that p53 physically binds to multiple domains of the hERalpha. This binding did not interfere with either the ERalpha dimerization or the interaction between hERalpha and its coactivator SRC-1. However, p53 did interfere with the hERalpha-ERE binding. These results may explain how p53 down-regulates the expression of some estrogen-responsive genes such as c-fos, c-jun, TPA, and bcl-2. This study supports the cross-talk between the p53 and the ERalpha signaling pathways. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10529369     DOI: 10.1006/bbrc.1999.1525

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  16 in total

1.  Resveratrol, through NF-Y/p53/Sin3/HDAC1 complex phosphorylation, inhibits estrogen receptor alpha gene expression via p38MAPK/CK2 signaling in human breast cancer cells.

Authors:  Francesca De Amicis; Francesca Giordano; Adele Vivacqua; Michele Pellegrino; Maria Luisa Panno; Donatella Tramontano; Suzanne A W Fuqua; Sebastiano Andò
Journal:  FASEB J       Date:  2011-07-07       Impact factor: 5.191

2.  Tumour suppressor p53 down-regulates the expression of the human hepatocyte nuclear factor 4alpha (HNF4alpha) gene.

Authors:  Yutaka Maeda; Wendy W Hwang-Verslues; Gang Wei; Takuya Fukazawa; Mary L Durbin; Laurie B Owen; Xuan Liu; Frances M Sladek
Journal:  Biochem J       Date:  2006-12-01       Impact factor: 3.857

3.  A single-nucleotide polymorphism in a half-binding site creates p53 and estrogen receptor control of vascular endothelial growth factor receptor 1.

Authors:  Daniel Menendez; Alberto Inga; Joyce Snipe; Oliver Krysiak; Gilbert Schönfelder; Michael A Resnick
Journal:  Mol Cell Biol       Date:  2007-01-22       Impact factor: 4.272

Review 4.  Is soy consumption good or bad for the breast?

Authors:  Leena Hilakivi-Clarke; Juan E Andrade; William Helferich
Journal:  J Nutr       Date:  2010-10-27       Impact factor: 4.798

5.  MDM2 regulates estrogen receptor α and estrogen responsiveness in breast cancer cells.

Authors:  Kyounghyun Kim; Robert Burghardt; Rola Barhoumi; Syng-Ook Lee; Xinyi Liu; Stephen Safe
Journal:  J Mol Endocrinol       Date:  2011-02-15       Impact factor: 5.098

6.  Ligand-dependent interaction of the glucocorticoid receptor with p53 enhances their degradation by Hdm2.

Authors:  S Sengupta; B Wasylyk
Journal:  Genes Dev       Date:  2001-09-15       Impact factor: 11.361

7.  An estrogen receptor-alpha/p300 complex activates the BRCA-1 promoter at an AP-1 site that binds Jun/Fos transcription factors: repressive effects of p53 on BRCA-1 transcription.

Authors:  Brandon D Jeffy; Jennifer K Hockings; Michael Q Kemp; Sherif S Morgan; Jill A Hager; Jason Beliakoff; Luke J Whitesell; G Timothy Bowden; Donato F Romagnolo
Journal:  Neoplasia       Date:  2005-09       Impact factor: 5.715

Review 8.  The p53-estrogen receptor loop in cancer.

Authors:  C Berger; Y Qian; X Chen
Journal:  Curr Mol Med       Date:  2013-09       Impact factor: 2.222

9.  Interaction between p53 and estradiol pathways in transcriptional responses to chemotherapeutics.

Authors:  Mattia Lion; Alessandra Bisio; Toma Tebaldi; Veronica De Sanctis; Daniel Menendez; Michael A Resnick; Yari Ciribilli; Alberto Inga
Journal:  Cell Cycle       Date:  2013-03-21       Impact factor: 4.534

10.  The extracellular matrix, p53 and estrogen compete to regulate cell-surface Fas/Apo-1 suicide receptor expression in proliferating embryonic cerebral cortical precursors, and reciprocally, Fas-ligand modifies estrogen control of cell-cycle proteins.

Authors:  Zulfiqar F Cheema; Daniel R Santillano; Stephen B Wade; Joseph M Newman; Rajesh C Miranda
Journal:  BMC Neurosci       Date:  2004-03-23       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.